SELLAS Life Sciences Group, Inc. SLS
7.77 USD -0.11 (-1.40%)
Nov 6, 2026, 11:13 AM EST
7.25 Day range 7.94
1.39 52-week range 15.88
- YTD
- +106.10%
- 1 year
- +379.63%
Financial health
Altman Z-Score
121.14 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Rating
C2 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 1